Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Viventia options anticancer hybridomas from M.D. Cancer Center

Oct. 14, 2002

U. of Kentucky researchers present novel camptothecin prodrugs

Oct. 11, 2002

Protein kinase inhibitors described by Pharmacia as useful for cancer and other disorders

Oct. 11, 2002

OSI-211 enters phase II trials in ovarian and small cell lung cancers

Oct. 11, 2002

New program for TLK-286 in combination with chemotherapy

Oct. 10, 2002

GEM-231 reported to increase the antitumor efficacy of irinotecan

Oct. 10, 2002

First 20 sites open in phase III trial of Xyotax in NSCLC

Oct. 9, 2002

Novel prodrugs of antitumor compounds designed by academic researchers

Oct. 9, 2002

Roche researchers identify new HDAC inhibitors

Oct. 8, 2002

Synergistic antitumor effect for irofulven combined with mitomycin D or thiotepa

Oct. 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...